In an amended S-1 filing, Xenon Pharmaceuticals (NASDAQ: XENE) set its IPO terms. The company plans to offer 4,000,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE